Aurora Cannabis (Aurora Cannabis) Debt-to-Asset : 0.13 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Aurora Cannabis Debt-to-Asset?

Aurora Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $18.6 Mil. Aurora Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $58.4 Mil. Aurora Cannabis's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $609.1 Mil. Aurora Cannabis's debt to asset for the quarter that ended in Dec. 2023 was 0.13.

Aurora Cannabis Debt-to-Asset Historical Data

The historical data trend for Aurora Cannabis's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Cannabis Debt-to-Asset Chart

Aurora Cannabis Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Debt-to-Asset

Get a 7-Day Free Trial

0.20

0.11

0.12

0.19

0.15

Aurora Cannabis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.22	0.25	0.19	0.16	0.13

Competitive Comparison of Aurora Cannabis's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurora Cannabis's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aurora Cannabis's Debt-to-Asset falls into.

Aurora Cannabis Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aurora Cannabis's Debt-to-Asset for the fiscal year that ended in Jun. 2021 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(33.5	+	293.464)	/	2131.531
	=	0.15

Aurora Cannabis's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(18.619	+	58.409)	/	609.099
	=	0.13

Aurora Cannabis (NAS:ACB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Aurora Cannabis Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Aurora Cannabis's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurora Cannabis (Aurora Cannabis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (NAS:ACB) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

21P1:Germany ACB:Canada

Address

3498 63 Avenue, Leduc, AB, CAN, T9E 0G8

Website

https://www.auroramj.com

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.